Niacinamide

"Niacinamide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake.

Descriptor ID	D009536
MeSH Number(s)	D03.066.515.530 D03.383.725.547.530
Concept/Terms	Niacinamide Niacinamide Vitamin B 3 B 3, Vitamin 3-Pyridinecarboxamide 3 Pyridinecarboxamide Vitamin B3 B3, Vitamin Nicotinamide Vitamin PP Papulex Papulex Nicotinsäureamid Jenapharm Nicotinsäureamid Jenapharm Jenapharm, Nicotinsäureamid Enduramide Enduramide Nicobion Nicobion

Below are MeSH descriptors whose meaning is more general than "Niacinamide".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Acids, Heterocyclic [D03.066]
Nicotinic Acids [D03.066.515]
Niacinamide [D03.066.515.530]
Heterocyclic Compounds, 1-Ring [D03.383]
Pyridines [D03.383.725]
Nicotinic Acids [D03.383.725.547]
Niacinamide [D03.383.725.547.530]

Below are MeSH descriptors whose meaning is related to "Niacinamide".

Below are MeSH descriptors whose meaning is more specific than "Niacinamide".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Niacinamide" by people in this website by year, and whether "Niacinamide" was a major or minor topic of these publications.

Bar chart showing 12 publications over 9 distinct years, with a maximum of 2 publications in 2010 and 2011 and 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	1	0	1
2006	0	1	1
2009	1	0	1
2010	0	2	2
2011	0	2	2
2012	1	1	2
2014	1	0	1
2024	1	0	1
2025	0	1	1

Below are the most recent publications written about "Niacinamide" by people in Profiles.

Ndhlovu LC, Giron LB, Galinskas J, Premeaux TA, Pang APS, Dias D, de Almeida Baptista MV, Shytaj IL, Maricato JT, Ferreira PRA, Gosuen G, Corley MJ, Friday CM, Bowler SA, Della Libera E, Sucupira MC, Hunter JR, Janini LM, Schechter M, Savarino A, Diaz RS. Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV. J Infect Dis. 2025 Nov 14; 232(5):1067-1077.

View in: PubMed
Rivera JC, Espinoza-Derout J, Hasan KM, Molina-Mancio J, Mart?nez J, Lao CJ, Lee ML, Lee DL, Wilson J, Sinha-Hikim AP, Friedman TC. Hepatic steatosis induced by nicotine plus Coca-Cola? is prevented by nicotinamide riboside (NR). Front Endocrinol (Lausanne). 2024; 15:1282231.

View in: PubMed
Noguchi S, Yamauchi Y, Takizawa H. Novel therapeutic strategies for fibrotic lung disease: a review with a focus on epithelial-mesenchymal transition. Recent Pat Inflamm Allergy Drug Discov. 2014 Jan; 8(1):9-18.

View in: PubMed
Zhao X, Tian C, Puszyk WM, Ogunwobi OO, Cao M, Wang T, Cabrera R, Nelson DR, Liu C. OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma. Lab Invest. 2013 Jan; 93(1):8-19.

View in: PubMed
Rangwala F, Williams KP, Smith GR, Thomas Z, Allensworth JL, Lyerly HK, Diehl AM, Morse MA, Devi GR. Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines. BMC Cancer. 2012 Sep 10; 12:402.

View in: PubMed
Zhang HL, Zhu Y, Wang CF, Yao XD, Zhang SL, Dai B, Shen YJ, Zhu YP, Shi GH, Ye DW. Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib. Int J Urol. 2011 Jun; 18(6):422-30.

View in: PubMed
Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, Xiao Y, Christie AL, Aster J, Settleman J, Gygi SP, Kung AL, Look T, Nakayama KI, DePinho RA, Wei W. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature. 2011 Mar 03; 471(7336):104-9.

View in: PubMed
Tang TC, Man S, Xu P, Francia G, Hashimoto K, Emmenegger U, Kerbel RS. Development of a resistance-like phenotype to sorafenib by human hepatocellular carcinoma cells is reversible and can be delayed by metronomic UFT chemotherapy. Neoplasia. 2010 Nov; 12(11):928-40.

View in: PubMed
Jones SJ, Laskin J, Li YY, Griffith OL, An J, Bilenky M, Butterfield YS, Cezard T, Chuah E, Corbett R, Fejes AP, Griffith M, Yee J, Martin M, Mayo M, Melnyk N, Morin RD, Pugh TJ, Severson T, Shah SP, Sutcliffe M, Tam A, Terry J, Thiessen N, Thomson T, Varhol R, Zeng T, Zhao Y, Moore RA, Huntsman DG, Birol I, Hirst M, Holt RA, Marra MA. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol. 2010; 11(8):R82.

View in: PubMed
Phillips JA, Morgan EL, Dong Y, Cole GT, McMahan C, Hung CY, Sanderson SD. Single-step conjugation of bioactive peptides to proteins via a self-contained succinimidyl bis-arylhydrazone. Bioconjug Chem. 2009 Oct 21; 20(10):1950-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals